Tirzepatide Mixing Calculator 

A tirzepatide mixing calculator does arithmetic only: it turns a vial amount and a water volume into a concentration, then turns a dose you enter into a draw volume in millilitres and in units on a 1 ml U-100 syringe. It does not choose a dose, it does not recommend a dose, and it does not replace your prescriber or your pharmacy label. Tirzepatide is a prescription-only medicine, and this page is written for people working with a prescriber direction and a labelled vial, not for anyone deciding a dose on their own.

Quick Answer

How to use this calculator

First, read the total milligrams printed on your vial, not the dose you intend to take, and type that into Vial Strength. Second, type the millilitres of bacteriostatic water you added, or that your pharmacy directions say to add, into Bacteriostatic Water. Third, type the single dose in milligrams that your prescriber directed into Desired Dose. Click Calculate and read all three outputs together: concentration tells you how strong each millilitre is, injection volume tells you how much liquid holds your dose, and syringe units tells you where to draw to on a 1 ml U-100 barrel.

Two habits prevent most errors. One, check the units on every number before you type it: vial strength and dose are both in milligrams here, water and injection volume are both in millilitres, and syringe units are a volume scale, not milligrams. Two, read the result back against your label: if the concentration does not match the concentration your pharmacy printed, one of your inputs is wrong, and the draw volume is wrong with it. Reset returns the worked example (10 mg, 2 ml, 2.5 mg) so you can re-run it after trying your own numbers.

The formula, in three steps

The tool does three divisions and nothing else. There is no titration schedule, no dose adjustment, and no allowance for waste, dead space in a needle, or liquid left in the vial, so the arithmetic answer is exact only for the numbers you typed.

The U-100 step is where the unit confusion lives. On a U-100 insulin syringe, 100 units equals exactly 1 ml, so 1 unit equals 0.01 ml. Units measure liquid volume, not drug amount: 50 units from a 5 mg/ml vial holds 2.5 mg, while 50 units from a 10 mg/ml vial holds 5 mg. Saying “50 units” without stating the concentration says nothing about the dose, which is why every result on this page prints concentration alongside units. If your syringe is not a U-100 syringe, do not use the units output at all; use the millilitre output with the syringe your pharmacist supplied, and ask them to confirm the conversion.

Worked example, checked by hand

Take the pre-filled numbers and run them without the calculator. A 10 mg vial plus 2 ml of water gives 10 divided by 2, which is 5 mg in every millilitre. A 2.5 mg amount needs 2.5 divided by 5, which is 0.5 ml. On a U-100 barrel, 0.5 ml times 100 is 50 units. Clicking Calculate gives the same three figures: 5.00 mg/ml, 0.50 ml, and 50 units. If your own run gives a different figure for these inputs, you have mistyped one of them, because the math has no other inputs to vary.

The same vial at a different water volume shows why water choice matters more than most people expect. At 1 ml of water the concentration doubles to 10.00 mg/ml and the same 2.5 mg amount draws to 0.25 ml, or 25 units. At 3 ml the concentration falls to 3.33 mg/ml and the draw grows to 0.75 ml, or 75 units. The dose never changed; only the water did. That is also why a chart copied from the internet is dangerous without its water volume: a units number belongs to one specific vial and water combination, and it is wrong for every other combination.

What the branded labels actually say, and why it does not set your dose here

Tirzepatide is the active ingredient in the FDA-approved branded products Mounjaro, for type 2 diabetes, and Zepbound, for chronic weight management and obstructive sleep apnea in adults with obesity. According to the DailyMed labels for both products, the recommended starting dosage is 2.5 mg injected under the skin once weekly for 4 weeks, and the 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage. From there the labels step up in 2.5 mg increments after at least 4 weeks on the current dose, with maintenance dosages of 5 mg, 10 mg or 15 mg once weekly for weight management and a maximum of 15 mg once weekly in adults.

That schedule is stated here for context only, and it must not be transferred to a compounded vial. The branded products are supplied as pens and vials with fixed concentrations and manufacturer directions, while a compounded vial concentration depends entirely on how much powder and water are in that vial. A 2.5 mg step on a branded label is not a direction to draw 2.5 mg from a compounded vial, and a maintenance figure on a branded label is not a dose for a compounded product. Your prescriber direction and your pharmacy label are the only dose sources for a compounded vial. If you are on a branded product, follow its manufacturer instructions and do not use this mixing calculator to re-derive a pen dose, because pens are not mixed by the patient in this way.

Compounded tirzepatide is not the branded product

The FDA states plainly that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness or quality before they are marketed. Its guidance on unapproved GLP-1 drugs adds that compounded versions should only be used in patients whose medical needs cannot be met by an FDA-approved drug, that patients should obtain a prescription from their doctor and fill it at a state-licensed pharmacy, and that claims a compounded drug is the same as an FDA-approved drug are a red flag. Poor compounding can produce a product with too much or too little active ingredient, or contamination, and the FDA has reported dosing errors with vial-and-syringe GLP-1 products.

Practically, that means three checks before you trust any number on this page. First, does your vial carry your name, a prescriber name, a pharmacy name and address, the drug and strength, and a beyond-use date? A product labelled for research use only, or with no patient name, was not dispensed to you as a prescription. Second, does the concentration on your pharmacy paperwork match the concentration this calculator gives from your vial amount and water volume? If not, stop. Third, are you following the storage and handling directions on your own label? Bacteriostatic Water for Injection, USP, as described on its DailyMed label, is a sterile, nonpyrogenic preparation containing 0.9% benzyl alcohol as a bacteriostatic preservative, supplied in a multiple-dose container for diluting or dissolving drugs. For opened multi-dose vials generally, CDC injection-safety guidance says to date the vial when first opened and discard within 28 days unless the manufacturer specifies a different date for that opened vial, but your own product label overrides any general rule, so follow the label date, not a chart.

Who this page is for, and who it is not for

This page is for prescriber-directed use: a patient or clinician who already has a prescribed dose and a labelled vial and needs to convert that dose into a draw volume. It is not a beginner guide to self-medication, and the old page language suggesting beginners could use it with guidance has been removed. It is not for anyone without a prescription, anyone deciding whether to start tirzepatide, anyone adjusting a dose because of side effects or a missed dose, or anyone using a product sold for research use. Those are prescriber decisions, and a calculator cannot make them.

If you need the opposite calculation, solving for how much water to add to reach a chosen draw volume, use the companion peptide reconstitution calculator, which is the generic, draw-first tool for any peptide and works in micrograms as well. This page stays water-first and tirzepatide-specific on purpose, so the two pages do not collapse into the same tool. For related unit work, the syringe calculator and the mg to IU calculator cover syringe volumes and milligram-to-unit conversions in general, the concentration calculator covers concentration from mass and volume for other solutions, and the semaglutide peptide calculator covers the other widely used GLP-1 peptide in the same water-first pattern.

Common mistakes this calculator cannot catch

First, confusing milligrams with units. A user who types a units number into the dose box, or reads a units result as milligrams, will be wrong by the concentration factor, which can be 5-fold or 10-fold. Always say the unit after every number: mg for drug amount, ml for liquid, units for barrel marks. Second, entering the dose in micrograms without converting: divide micrograms by 1,000 to get milligrams before typing, because this tool accepts milligrams only and does not handle microgram dosing. A 2,500 microgram amount is 2.5 mg; typing 2,500 into the dose box would give a draw 1,000 times too large, and the over-100-units warning should stop you, but the correct fix is the conversion, not a smaller water volume.

Third, using the wrong syringe. A U-40 or U-500 barrel, a tuberculin syringe marked in millilitres, and a 1 ml U-100 barrel all read differently, and only the U-100 barrel matches the units output. Fourth, reading the plunger from the wrong edge or at an angle: read at eye level, at the edge of the plunger seal nearest the needle, on a vertical syringe. Fifth, assuming the vial contains exactly the labelled amount after mixing, with no loss: needle dead space, liquid clinging to the vial, and incomplete dissolving all reduce what you can actually draw, so a vial that arithmetically holds four 2.5 mg doses from 10 mg may not deliver four full doses in practice. Do not plan a vial around exact division without allowing for that loss, and ask your pharmacist how many doses your vial is actually expected to supply.

What competing calculators miss

Most tirzepatide calculators in the top results give the same three divisions and stop, often with a table of common draws and no warning when a draw exceeds the syringe. This page adds the over-100-units warning and the dose-exceeds-vial warning inside the result itself, so the failure mode is visible where the number is read, not buried in a table footnote. Many rivals also mix branded dose schedules with compounded vial math in the same table, which invites a reader to treat a branded starting dose as a compounded dose. This page keeps those worlds apart: the branded schedule is described as branded-label context, and the calculator itself takes only a prescriber-directed dose for a specific vial.

Another gap is the water-first versus draw-first distinction. Several generic peptide tools solve for water given a desired draw, which is a different question from the one here, and readers who land on the wrong tool get an answer to a question they did not ask. This page states its direction in the first paragraph and links to the draw-first generic tool for the other direction, rather than adding a second mode that would erase the distinction. Finally, few rivals state the syringe assumption on every result. This page prints “on 1ml syringe” with every units figure and repeats the U-100 definition in the results note, because a units number without its syringe is not a complete answer.

Frequently asked questions

Add This Calculator to Your Website

References